Skip to main content

Twist Bioscience Corp 10-K for FY2026

Twist Bioscience Corp (TWST)

10-K 2026-11-16 For: 2026-09-30
View Original
Added on November 17, 2026

About this 10-K

Twist Bioscience Corp filed this 10-K on November 16, 2026, covering the fiscal year ended September 30, 2026 (FY2026).

Twist Bioscience reported revenue up 22% to $459.4 million for fiscal 2026 from $376.6 million, while net loss widened to $130.2 million from $77.7 million. AI summary

Headline figures

Fiscal year ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$459.43M
up 22.0% from $376.57M a year earlier
Net loss
$130.2M
compared with a net loss of $77.67M a year earlier
Diluted EPS
-$2.08
compared with -$1.30 a year earlier